KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Biology

Cancer Oncology

Physics

Medicine

Internal Medicine

Show all topics

DOI

10.1016/s0140-6736(21)01222-8